when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Minoryx Therapeutics sl — leriglitazone hydrochloride (Regulatory A… · pharmadog

pharmadog
calendar
regulatory approval eu

regulatory approval_eu

Minoryx Therapeutics sl — leriglitazone hydrochloride (Regulatory Approval (EU))

April 26, 2026leriglitazone hydrochlorideupdated 3mo ago

community read0 votes

Therapy area: Metabolic Disorders. Indication: Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD))